Does PALBOCICLIB Cause Decreased appetite? 3,400 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,400 reports of Decreased appetite have been filed in association with PALBOCICLIB (Ibrance). This represents 3.7% of all adverse event reports for PALBOCICLIB.
3,400
Reports of Decreased appetite with PALBOCICLIB
3.7%
of all PALBOCICLIB reports
238
Deaths
757
Hospitalizations
How Dangerous Is Decreased appetite From PALBOCICLIB?
Of the 3,400 reports, 238 (7.0%) resulted in death, 757 (22.3%) required hospitalization, and 31 (0.9%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PREDNISONE (3,390)
LENVATINIB (3,257)
ETANERCEPT (3,201)
Which PALBOCICLIB Alternatives Have Lower Decreased appetite Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID